Brandon Capital

Brandon Capital is a leading life science venture capital firm that manages the Medical Research Commercialisation Fund (MRCF), Australia and New Zealand's largest life science investment fund. Established in 2008, the firm specializes in bridging the gap between academic research and commercialized medical products by providing seed and venture stage funding. Brandon Capital operates an international model with offices in Melbourne, Sydney, London, and Palo Alto, supporting a portfolio of companies developing innovative therapies and medical devices. The firm is backed by major Australian superannuation funds and works closely with over 50 leading medical research institutes and hospitals. This collaborative approach enables the translation of world-class research into innovative clinical solutions for patients globally.